Profile data is unavailable for this security.
About the company
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
- Revenue in ILS (TTM)53.37bn
- Net income in ILS4.36bn
- Incorporated1944
- Employees31.17k
- LocationTeva Pharmaceutical Industries Ltd124 Dvora Hanevi'a St.TEL AVIV-YAFO 6944020IsraelISR
- Phone+972 39148213
- Fax+972 39234050
- Websitehttps://www.tevapharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hansoh Pharmaceutical Group Company Ltd | 5.92bn | 2.15bn | 80.46bn | 9.31k | 36.88 | 5.66 | 34.73 | 13.60 | 0.911 | 0.911 | 2.51 | 5.93 | 0.3952 | 1.93 | 4.68 | 1,664,721.00 | 14.33 | 11.36 | 16.01 | 13.27 | 90.84 | 90.68 | 36.25 | 30.80 | 8.38 | -- | 0.0037 | 28.12 | 21.35 | 7.15 | 33.39 | 11.33 | -5.71 | -- |
| Royalty Pharma plc | 7.36bn | 2.39bn | 81.04bn | 100.00 | 25.51 | 4.05 | 29.28 | 11.01 | 1.78 | 1.78 | 4.21 | 11.22 | 0.1257 | -- | 84.52 | 23,781,930.00 | 7.00 | 6.72 | 9.03 | 9.10 | -- | -- | 55.68 | 50.56 | -- | 7.06 | 0.4795 | 50.52 | 5.06 | 2.30 | -10.25 | 9.26 | -4.90 | 24.01 |
| Biogen Inc | 30.60bn | 4.00bn | 83.94bn | 7.50k | 20.99 | 1.49 | 13.09 | 2.74 | 8.81 | 8.81 | 67.37 | 124.45 | 0.3441 | 1.04 | 5.30 | 1,318,747.00 | 4.50 | 6.70 | 5.32 | 7.93 | 75.69 | 78.49 | 13.07 | 17.28 | 2.03 | 5.74 | 0.2562 | 0.00 | 2.22 | -5.96 | -20.79 | -20.22 | -19.60 | -- |
| Astellas Pharma Inc | 40.40bn | 6.33bn | 85.29bn | 13.64k | 13.39 | 2.44 | 8.45 | 2.11 | 179.57 | 179.57 | 1,145.43 | 984.21 | 0.5841 | 1.27 | 2.90 | 151,038,200.00 | 9.15 | 3.05 | 14.11 | 4.45 | 81.00 | 81.15 | 15.67 | 5.42 | 0.839 | 41.32 | 0.2913 | 131.42 | 19.25 | 8.01 | 197.72 | -23.64 | -5.94 | 13.09 |
| Daiichi Sankyo Co Ltd | 40.23bn | 5.97bn | 106.48bn | 19.77k | 17.52 | 3.10 | 14.34 | 2.65 | 163.62 | 163.62 | 1,103.05 | 924.09 | 0.5649 | 0.8183 | 3.11 | 103,827,400.00 | 8.38 | 5.72 | 10.55 | 7.11 | 77.54 | 72.15 | 14.84 | 11.03 | 1.85 | -- | 0.1495 | 49.57 | 17.77 | 13.95 | 44.47 | 17.77 | 29.01 | 20.79 |
| Otsuka Holdings Co Ltd | 48.40bn | 7.12bn | 107.10bn | 35.34k | 14.68 | 1.75 | 11.32 | 2.21 | 685.26 | 685.26 | 4,657.43 | 5,743.73 | 0.6221 | 2.08 | 4.57 | 69,865,070.00 | 9.23 | 5.91 | 11.37 | 7.27 | 71.68 | 69.18 | 14.83 | 9.89 | 1.67 | -- | 0.0685 | 32.93 | 15.42 | 10.78 | 182.13 | 21.96 | 15.32 | 3.71 |
| Sandoz Group AG | 34.51bn | 2.83bn | 110.66bn | 23.57k | 38.88 | 3.75 | 24.52 | 3.21 | 1.62 | 1.62 | 19.81 | 16.82 | 0.5321 | 2.04 | 4.73 | 367,229.00 | 4.36 | 2.92 | 6.36 | 4.74 | 48.39 | 48.12 | 8.19 | 5.46 | 0.7716 | 8.55 | 0.3778 | 34.69 | 7.44 | 2.93 | -- | 14.62 | 19.18 | -- |
| Teva Pharmaceutical Industries Ltd | 53.37bn | 4.36bn | 115.52bn | 31.17k | 26.45 | 4.66 | 15.52 | 2.16 | 3.75 | 3.75 | 46.06 | 21.28 | 0.431 | 2.64 | 5.10 | 1,712,181.00 | 3.50 | -1.47 | 5.25 | -2.08 | 52.72 | 50.58 | 8.13 | -4.04 | 0.8002 | 4.54 | 0.6799 | -- | 4.32 | 0.709 | 186.03 | -- | -2.82 | -- |
| Bayer AG | 163.81bn | -13.01bn | 128.50bn | 88.08k | -- | 1.38 | 59.29 | 0.7844 | -3.68 | -3.68 | 46.39 | 26.41 | 0.4232 | 1.45 | 5.05 | 517,439.10 | -3.34 | -0.6682 | -4.68 | -0.9173 | 58.76 | 58.87 | -7.89 | -1.66 | 0.6301 | 2.33 | 0.5905 | -- | -2.21 | 1.94 | -41.85 | -- | 0.5643 | -44.01 |
| Alnylam Pharmaceuticals, Inc. | 11.49bn | 970.64m | 131.57bn | 2.50k | 142.82 | 53.79 | 115.12 | 11.45 | 2.25 | 2.25 | 27.82 | 5.96 | 0.8068 | 8.46 | 7.20 | 1,485,575.00 | 6.82 | -12.28 | 9.57 | -16.14 | 81.64 | 83.20 | 8.45 | -24.70 | 2.71 | 3.50 | 0.7737 | -- | 65.19 | 49.77 | 212.79 | -- | -3.56 | -- |
| Haleon PLC | 45.77bn | 6.92bn | 139.36bn | 24.00k | 20.37 | 2.04 | 16.46 | 3.04 | 0.185 | 0.185 | 1.22 | 1.84 | 0.3295 | 3.52 | 5.17 | -- | 5.02 | 3.99 | 5.99 | 4.64 | 64.69 | 62.89 | 15.23 | 12.64 | 0.7146 | 9.57 | 0.3431 | 30.35 | -1.81 | 2.20 | 15.60 | 7.80 | 5.37 | -- |
| Sun Pharmaceutical Industries Ltd | 19.12bn | 3.53bn | 145.29bn | 43.00k | 41.18 | -- | 32.21 | 7.60 | 43.70 | 45.45 | 236.59 | -- | -- | -- | -- | 13,211,420.00 | -- | 9.09 | -- | 12.38 | 79.97 | 73.38 | 18.62 | 16.07 | -- | -- | -- | 39.34 | 8.42 | 9.87 | 14.12 | 23.76 | 6.66 | 31.95 |
Data as of Mar 06 2026. Currency figures normalised to Teva Pharmaceutical Industries Ltd's reporting currency: Israeli Shekel ILS
17.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Harel Mutual Funds Ltd.as of 31 Dec 2025 | 72.33m | 6.31% |
| The Vanguard Group, Inc.as of 31 Jan 2026 | 39.79m | 3.47% |
| Norges Bank Investment Managementas of 31 Dec 2025 | 39.36m | 3.43% |
| KSM Mutual Funds Ltd.as of 31 Dec 2025 | 13.25m | 1.16% |
| Meitav Mutual Funds Ltd.as of 31 Dec 2025 | 12.89m | 1.12% |
| Migdal Mutual Funds Ltd.as of 31 Dec 2025 | 7.41m | 0.65% |
| IBI Mutual Funds Management (1978) Ltd.as of 31 Dec 2025 | 3.04m | 0.27% |
| Charles Schwab Investment Management, Inc.as of 05 Feb 2026 | 2.49m | 0.22% |
| Canada Pension Plan Investment Boardas of 31 Mar 2024 | 2.48m | 0.22% |
| Psagot Mutual Funds Ltd.as of 31 Dec 2025 | 1.98m | 0.17% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
